Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$8.06 +0.43 (+5.64%)
At close: Nov 11, 2026 · 4:00 PM EST

Eupraxia Pharmaceuticals (EPRX) Receivables - Net (2022 - 2026)

Updated

Analysis

Eupraxia Pharmaceuticals (EPRX) Receivables - Net (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Eupraxia Pharmaceuticals 304.87 Mn -174.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 202,171.00
Jun 30, 2026 688,219.00
Mar 31, 2026 663,235.00
Dec 31, 2025 716,095.00
Sep 30, 2025 139,904.00
Jun 30, 2025 134,607.00
Mar 31, 2025 238,531.00
Dec 31, 2024 258,074.00
Sep 30, 2024 105,930.00
Jun 30, 2024 155,235.00
Mar 31, 2024 167,243.00
Dec 31, 2023 153,749.00
Dec 31, 2022 89,715.00
API Access

Eupraxia Pharmaceuticals Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=EPRX&period=max&api_key=YOUR_API_KEY